Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorStennes, Matthew L.en_US
dc.date.accessioned2012-08-23T11:11:50Z
dc.date.issued1997en_US
dc.identifier.citationThe Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases (1997 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:9453691
dc.description.abstractNajarian and Burzynski seem the perfect examples of the amazing potential of the American medical establishment. Their visionary work in their respective fields should be celebrated as monumental contributions to society. Rather than being lauded by the nation, though, both men have watched their careers and reputations come hurtling to a disastrous end as they faced criminal charges of fraud, embezzlement, and multiple violations of Food and Drug Administration (FDA) laws which threatened to send them each to prison for the rest of their lives.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectFDA misdirectionen
dc.subjectregulation of physician prescribingen
dc.subjecthuman drugsen
dc.subjectNajarianen
dc.subjectBurzynskien
dc.titleThe Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Casesen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-08-23T11:11:50Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record